Ankle Arthrodesis (Ankle Joint Fusion) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Ankle arthrodesis — commonly known as ankle joint fusion — is a surgical procedure that permanently eliminates the tibiotalar joint by fusing the tibia and talus into a single bone unit. By eliminating motion at the arthritic joint, the procedure reliably abolishes the pain generated by bone-on-bone contact in end-stage ankle arthritis. It is one of the most functionally effective and durable surgeries available for severe ankle joint destruction, with a history of use spanning over a century.

The procedure involves removing all remaining articular cartilage from the distal tibia and talar dome, preparing the subchondral bone surfaces to achieve optimal bony apposition, and stabilising the joint in a neutral functional position using internal fixation (cannulated screws, intramedullary nails, or plates) or external fixation (ring fixators for complex cases or infected joints). The two bony surfaces then heal together through the same biological process as fracture healing, producing a solid osseous union.

Ankle arthrodesis is the gold standard surgical treatment for end-stage ankle arthritis and remains the most widely performed salvage procedure for the ankle joint. Despite eliminating tibiotalar motion (plantarflexion/dorsiflexion), compensatory motion in the subtalar and midtarsal joints allows patients to walk with a near-normal gait pattern. Patient satisfaction rates are consistently high in well-selected patients, and the procedure has excellent long-term durability — a major advantage over total ankle replacement.

Post-traumatic osteoarthritis is the most common indication for ankle arthrodesis, accounting for approximately 60–70% of cases. Severe ankle fractures, tibial plafond fractures (pilon fractures), and chronic ankle instability progressively destroy the articular cartilage over years or decades, leading to end-stage joint destruction. Primary osteoarthritis of the ankle — less common than hip or knee OA — is a second indication. Inflammatory arthropathies (rheumatoid arthritis, psoriatic arthritis) affecting the ankle are treated with arthrodesis when medical management has failed and joint destruction is advanced.

Avascular necrosis (osteonecrosis) of the talus — caused by trauma, corticosteroid use, alcohol excess, or idiopathic causes — produces collapse of the talar dome and secondary ankle arthritis. Arthrodesis incorporating the compromised talus, sometimes with bone grafting or subtalar joint inclusion (tibiotalocalcaneal fusion), is required. Charcot neuroarthropathy of the ankle in diabetic or other neuropathic patients produces severe joint destruction and deformity managed with staged reconstruction and arthrodesis. Failed total ankle replacement requiring revision to fusion is an increasing indication as ankle arthroplasty rates rise.

The ideal candidate for ankle arthrodesis is a patient with end-stage ankle arthritis confirmed on weight-bearing radiographs (severe joint space narrowing, subchondral sclerosis, osteophyte formation, deformity) and disabling pain that has failed conservative management — comprising physiotherapy, ankle-foot orthoses (AFO), NSAID or intra-articular injection therapy — for at least 6–12 months. Patients with high physical activity demands (manual workers, farmers, athletes performing high-impact activities) may prefer fusion to ankle replacement due to the superior durability under loading.

Relative contraindications for arthrodesis (and considerations for ankle replacement instead) include: age under 50 with low physical demand and preserved subtalar motion (who may better tolerate the mobility loss from fusion); avascular necrosis of the talus with large volume talar necrosis (technically challenging fusion); and inadequate bone stock insufficient for screw fixation. Absolute contraindications include active ankle infection (staged surgery required — fixation can proceed only after infection eradication), significant peripheral vascular disease (poor wound healing), uncontrolled peripheral neuropathy without correction of deformity, and severe osteoporosis that cannot reliably hold fixation.

Arthroscopic ankle fusion (AAF) is the preferred technique for most straightforward cases without significant deformity or bone loss. Using arthroscopic portals, cartilage is debrided and the joint surfaces are prepared with motorised shavers and burrs. Two or three cannulated screws are inserted percutaneously across the tibiotalar joint under fluoroscopic guidance. Arthroscopic fusion offers lower wound complication rates, shorter hospital stay, and equivalent union rates to open surgery — typically 85–95% primary union.

Open ankle fusion is required when arthroscopic access is insufficient — particularly for cases with significant angular deformity (>15° valgus or varus), large bone defects requiring structural grafting, or revision surgery. Anterior, lateral (transfibular), and medial approaches are used depending on deformity and surgeon preference. Transfibular approaches provide the broadest joint exposure. Fixation choices include crossed 7.3 mm cannulated screws (most common), anterior plating, or retrograde intramedullary nailing — the nail passing from the plantar heel through the calcaneus, talus, and into the tibia, providing excellent stability for salvage cases and tibiotalocalcaneal fusion.

Timiotalocalcaneal (TTC) fusion — fusing both the tibiotalar and subtalar joints simultaneously — is performed for cases with combined subtalar arthritis, talar avascular necrosis, or Charcot arthropathy. Retrograde intramedullary nails (Weil-Cardan, DJO Versa Nail) are the fixation of choice for TTC fusion. Bone graft — autograft (iliac crest), allograft, or bone graft substitutes — is added when structural support or biological augmentation is required.

Ankle arthrodesis reliably achieves significant pain relief in the large majority of patients. Literature consistently reports patient satisfaction rates of 75–90% at medium and long-term follow-up. Union rates with modern internal fixation techniques are 85–95% for primary arthroscopic cases; slightly lower (80–90%) for open surgery with deformity correction. The AOFAS ankle-hindfoot score typically improves from pre-operative values of 30–45 to post-operative values of 65–80 at 12 months.

Gait analysis studies demonstrate that well-fused ankles produce near-normal walking velocity and cadence, with compensatory plantarflexion from the ipsilateral first ray and midtarsal joints. Long-term studies (10–20 year follow-up) demonstrate durable outcomes without the implant wear, loosening, or revision risk that affects total ankle replacement. Patients with solid fusion can return to manual work and moderate recreational activity. A systematic review by Haddad et al. (Foot Ankle Int, 2007) comparing arthrodesis and TAR found comparable functional outcomes but different risk profiles: arthrodesis had lower reoperation rates at long-term follow-up.

Non-union — failure of the arthrodesis site to achieve solid bony fusion — is the most significant complication, occurring in 5–15% of cases. Risk factors for non-union include smoking (which impairs bone healing by reducing osteoprogenitor cell activity and vascular supply — patients are strongly advised to stop smoking at least 6 weeks pre-operatively), diabetes mellitus, peripheral vascular disease, prior infection, and inadequate fixation. Non-union is treated with revision surgery including improved fixation and bone grafting.

Malunion — fusion healing in a non-optimal position — can produce gait abnormalities and accelerate subtalar or midtarsal joint degeneration. The ideal fusion position is 0–5° valgus, neutral dorsiflexion, and 5–10° external rotation. Wound healing complications are higher in open versus arthroscopic approaches (5–15% versus 1–3%). Hardware irritation from prominent screw heads may require elective removal in 10–15% of cases. Progressive subtalar and midtarsal arthritis develops in some patients over decades due to the altered mechanical loading of the hindfoot following tibiotalar fusion, potentially requiring further fusion surgery. Deep infection (<2%), complex regional pain syndrome CRPS (<2%), and sural nerve injury are additional recognised risks.

Following ankle arthrodesis, the rehabilitation protocol is structured around bone healing timelines. Patients are typically non-weight-bearing in a plaster back slab for 2 weeks for wound healing, then transition to a below-knee cast or removable boot for 4–6 weeks. Partial weight-bearing is introduced at 6–8 weeks once early radiographic callus formation is evident. Full weight-bearing in a walker boot is permitted at 8–12 weeks, with transition to normal footwear (often with a rocker-bottom sole modification) at 10–16 weeks depending on radiographic union progress.

Serial weight-bearing radiographs at 6, 12, and 24 weeks assess progression of fusion. CT scanning is used to confirm union if plain radiographs are equivocal. Physiotherapy commences from the early post-operative period focusing on calf muscle activation, subtalar and midtarsal range-of-motion exercises, and progressive weight-bearing gait training. Shoe modifications — including rocker-bottom soles, ankle-foot orthoses, or custom insoles — may be prescribed to optimise gait mechanics. Complete recovery and return to full activity typically requires 9–12 months. Driving return is typically at 6–8 weeks for automatic transmission; 3–4 months for manual if the operated ankle is the right ankle.

In the United States, ankle arthrodesis (surgical implants, anaesthesia, and hospitalisation) typically costs $15,000–35,000, with surgeon fees adding $5,000–10,000 for complex cases. In the United Kingdom, the procedure is available via the NHS for eligible patients at no direct cost, with private sector costs of £8,000–15,000. Australian and Canadian public healthcare covers the procedure, though wait times apply.

Medical tourism for ankle arthrodesis offers substantial cost savings. In India, JCI-accredited orthopaedic hospitals in Chennai, Hyderabad, Delhi, and Mumbai perform arthroscopic and open ankle fusions at $3,000–6,000 total package cost including surgery, fixation hardware, hospitalisation, physiotherapy, and surgeon fees — a saving of 75–85% versus US prices. Thailand's leading orthopaedic hospitals (Bumrungrad, Bangkok Hospital, Samitivej) offer arthrodesis at $6,000–10,000. Turkey, Poland, and Mexico are additional high-quality lower-cost destinations with trained foot and ankle surgeons. Patients should confirm the surgical team's subspecialty foot and ankle training and implant system compatibility for any potential need for revision surgery on return.

Total ankle replacement (TAR) is the principal surgical alternative to arthrodesis for end-stage ankle arthritis. TAR preserves tibiotalar motion, potentially protecting adjacent joints from accelerated arthritis, and produces better energy expenditure and gait kinetics in the short-to-medium term. Current generation implants (STAR, HINTEGRA, Infinity, INBONE) have 10-year survival rates of 80–90%. However, TAR has higher revision rates than arthrodesis, is more technically demanding, is less appropriate for patients with deformity exceeding 15°, and is less durable under high-demand loading — making arthrodesis preferable for younger high-demand patients and those with deformity, bone deficiency, or avascular necrosis.

Conservative alternatives before surgery include structured physiotherapy, custom ankle-foot orthoses to offload the joint, corticosteroid or hyaluronic acid intra-articular injections, activity modification, and appropriate footwear modifications. Ankle distraction arthroplasty — a technique using an external fixation frame to distract the joint and promote fibrocartilage repair — is a motion-preserving alternative for younger patients with moderate arthritis, studied mainly in Dutch centres. Supramalleolar osteotomy can correct alignment and redistribute load, potentially delaying or avoiding arthrodesis in patients with unicompartmental ankle arthritis and malalignment.